Novartis Ag (NVS) Total Non-Current Liabilities (2009 - 2026)

Novartis Ag's Total Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $100.0 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $100.0 million (changed N/A YoY), while the FY2025 annual figure was $37.1 billion, up 26.15% from the prior year.
• Total Non-Current Liabilities came in at $100.0 million for Q1 2026 at Novartis Ag, down from $37.1 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $37.1 billion in Q4 2025 to a low of $100.0 million in Q1 2026.
• A 5-year average of $26.8 billion and a median of $29.4 billion in 2022 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 51.45% in 2022 and fell 15.87% in 2023, its largest moves.
• Novartis Ag's Total Non-Current Liabilities stood at $29.4 billion in 2022, then slipped by 8.75% to $26.8 billion in 2023, then climbed by 9.79% to $29.4 billion in 2024, then gained by 26.15% to $37.1 billion in 2025, then plunged by 99.73% to $100.0 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $100.0 million, $37.1 billion, and $30.6 billion for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison